SLC5A2 and Hyperglycemia: Since blockade of SGLT2 promotes urinary glucose excretion and resultantly improves hyperglycemia in an insulin-independent manner, SGLT2 inhibitors are now one of the widely used agents for the treatment of diabetes [9–11].